/MSOS
MSOS Stock - AdvisorShares Pure US Cannabis ETF
Financial Services|Asset ManagementAMEX
$4.54-6.97%
$0.34 (-6.97%) • Dec 22
77
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.90
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $4.99
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MSOS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$4.49 – $4.59
TARGET (TP)$5.22
STOP LOSS$4.18
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.48
52W High$7.25
52W Low$2.02
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
Loading analyst ratings...
Earnings History & Surprises
MSOSLoading earnings data...
Latest News
AdvisorShares Issues Statement on Executive Order to Reclassify Cannabis; MSOS Portfolio Manager Calls Executive Action A Pivotal Moment For Cannabis Policy
📈 PositiveBenzinga•Dec 18, 2025, 09:41 PM
Marijuana stocks sell off as Trump signs executive order to reclassify cannabis
📉 NegativeDowjones•Dec 18, 2025, 09:24 PM•Also: , ,
Cannabis stocks selling off as Trump signs rescheduling order
📉 NegativeSeeking Alpha•Dec 18, 2025, 07:21 PM•Also: , ,
U.S. Centers For Medicare & Medicaid Services Administrator Says Millions Of Americans On Medicare To Become Eligible To Receive CBD As Early As April
📈 PositiveBenzinga•Dec 18, 2025, 06:59 PM•Also: , ,
Trump Order Will Direct Maintaining Restrictions On Dangerous Products; Centers For Medicare & Medicaid Services Plans To Allow Beneficiaries To Benefit From Hemp-derived Cbd Products At No Cost; Trump Order Will Not Encourage Use, But Recognizes Potential Both Therapeutic Uses And Risks Like Addiction; Marijuana Will Remain Illegal To Possess Under Federal Law; Trump Order Makes No Changes To Criminal Penalties Or Access For Recreational Use Of Marijuana
➖ NeutralBenzinga•Dec 18, 2025, 06:51 PM•Also: , ,
Trump To Sign Executive Order On Thursday Aiming To Expedite Reclassification Of Marijuana As Schedule III Substance; Trump Order Will Allow More Research Of Medical Marijuana And Cannabidiol; Trump Order Will Help U.s. To Better Understand Risks Associated With Marijuana; There Is Currently Insufficient Evidence Of Marijuana's Medical Uses; Trump Order Will Direct White House To Work With Congress To Improve Access To Hemp-Derived CBD Products
📈 PositiveBenzinga•Dec 18, 2025, 06:49 PM•Also: , ,
'Trump's Marijuana Executive Order Details Leaked Ahead Of Announcement, Including CBD And Hemp Provisions'- Marijuana Moment
📈 PositiveBenzinga•Dec 18, 2025, 05:50 PM•Also: , ,
'Trump's Marijuana Rescheduling Order Could Include Industry Banking And CBD Medicare Coverage Provisions, Sources Say;'- Marijuana Moment
📈 PositiveBenzinga•Dec 17, 2025, 05:01 PM•Also: , ,
Shares of cannabis-linked stocks are trading higher following reports suggesting President Trump will sign an executive order that will reclassify marijuana to a Schedule III drug.
📈 PositiveBenzinga•Dec 17, 2025, 02:38 PM•Also: , ,
Shares of cannabis-linked stocks are trading higher after President Donald Trump confirmed his administration is strongly considering reclassifying marijuana.
📈 PositiveBenzinga•Dec 16, 2025, 07:17 PM•Also: , ,
Liz Claman Posts On X "ALERT: Word is a @realDonaldTrump executive order to reclassify cannabis/marijuana as less dangerous, less regulated Class III substance
📈 PositiveBenzinga•Dec 15, 2025, 08:48 PM•Also: , ,
AdvisorShares Pure US Cannabis ETF Shares Resume Trade Following Circuit Breaker Halt
➖ NeutralBenzinga•Dec 15, 2025, 08:46 PM
President Trump Says Considering Executive Oder To Reclassify Marijuana
➖ NeutralBenzinga•Dec 15, 2025, 08:45 PM•Also: , ,
Shares of cannabis-linked stocks are trading higher following a report suggesting that President Trump is expected to reclassify marijuana as a Schedule III drug.
📈 PositiveBenzinga•Dec 12, 2025, 01:23 PM•Also: , ,
The Washington Post Reported Thursday, President Trump Plans Order To Reclassify Marijuana As Schedule III Drug, Aligning It With Prescription Painkillers
📈 PositiveBenzinga•Dec 12, 2025, 10:07 AM
'Nebraska Supreme Court Hears Case Seeking To Overturn Medical Marijuana Law Approved By Voters' - Marijuana Moment
➖ NeutralBenzinga•Dec 4, 2025, 01:59 PM•Also: , ,
UPDATE: 'Medicare to Test Making CBD Treatment Available for Seniors' - Bloomberg News
📈 PositiveBenzinga•Nov 26, 2025, 05:58 PM•Also: , ,
Watching Marijuana ETFs; Traders Circulate Medicare To Test Making CBD Treatment Available For Seniors
📈 PositiveBenzinga•Nov 26, 2025, 05:32 PM•Also:
'Marijuana Banking Bill Is 'On The Back Burner,' As Congressional Lawmakers See No Indication It'll Advance Soon' - Marijuana Moment
📉 NegativeBenzinga•Nov 25, 2025, 03:27 PM•Also: , ,
Shares of cannabis-linked stocks are trading higher after US House Representative Mast joined the Marijuana 1-to-3 Act of 2025 as its newest cosponsor.
📈 PositiveBenzinga•Nov 24, 2025, 05:02 PM•Also: , ,
Frequently Asked Questions about MSOS
What is MSOS's current stock price?
AdvisorShares Pure US Cannabis ETF (MSOS) is currently trading at $4.54 per share. The stock has moved -6.97% today.
What is the analyst price target for MSOS?
No analyst price targets are currently available for this stock.
What sector is AdvisorShares Pure US Cannabis ETF in?
AdvisorShares Pure US Cannabis ETF operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the AMEX exchange.
What is MSOS's market cap?
AdvisorShares Pure US Cannabis ETF has a market capitalization of $0.77 billion, making it a small-cap company.
Does MSOS pay dividends?
No, AdvisorShares Pure US Cannabis ETF does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorAVLC
Avantis U.S. Large Cap Equity ETF
$79.19
Mkt Cap: $0.9B
BBEM
J.P. Morgan Exchange-Traded Fund Trust - JPMorgan BetaBuilders Emerging Markets Equity ETF
$64.15
Mkt Cap: $0.7B
ECH
iShares MSCI Chile ETF
$39.79
Mkt Cap: $0.9B
GWX
SPDR S&P International Small Cap ETF
$40.73
Mkt Cap: $0.8B
IVES
Dan IVES Wedbush AI Revolution ETF
$32.29
Mkt Cap: $0.7B
JHMD
John Hancock Multifactor Developed International ETF
$41.90
Mkt Cap: $0.9B
PGF
Invesco Financial Preferred ETF
$14.16
Mkt Cap: $0.8B
SCHQ
Schwab Long-Term U.S. Treasury ETF
$31.70
Mkt Cap: $0.8B
THYF
T. Rowe Price U.S. High Yield ETF
$52.51
Mkt Cap: $0.8B
XBIL
The RBB Fund, Inc. - US Treasury 6 Month Bill ETF
$50.18
Mkt Cap: $0.8B
Explore stocks similar to MSOS for comparison